Compare SNAL & ONMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SNAL | ONMD |
|---|---|---|
| Founded | 2000 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | |
| Sector | Technology | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.2M | 25.0M |
| IPO Year | 2022 | 2021 |
| Metric | SNAL | ONMD |
|---|---|---|
| Price | $2.28 | $4.21 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 37.1K | 28.7K |
| Earning Date | 11-11-2026 | 11-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 120.00 | 83.33 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $81,225,622.00 | $1,359,000.00 |
| Revenue This Year | $22.50 | N/A |
| Revenue Next Year | $9.55 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 111.35 |
| 52 Week Low | $0.59 | $0.63 |
| 52 Week High | $21.60 | $115.00 |
| Indicator | SNAL | ONMD |
|---|---|---|
| Relative Strength Index (RSI) | 46.54 | 29.41 |
| Support Level | $2.10 | $3.61 |
| Resistance Level | $2.63 | $4.99 |
| Average True Range (ATR) | 0.22 | 0.34 |
| MACD | 0.05 | 0.90 |
| Stochastic Oscillator | 60.00 | 48.55 |
Snail Inc is an independent developer and publisher of interactive digital entertainment for consumers around the world, with a portfolio of premium games designed for use on a variety of platforms, including consoles, PC's, and mobile devices. The geographic presence of the company is in the United States and the International market, where the majority of its revenue comes from the United States. The Company has one operating and reportable segment. The company operates in the USA, the UK and Other Countries.
OneMedNet Corp is a healthcare software company with solutions focused on digital medical image management, exchange, and sharing. It is a provider of clinical imaging innovation and curator of regulatory-grade Imaging Real World Data(iRWDTM). Its solutions connect healthcare providers and patients, satisfying a crucial need within the life sciences field, offering direct access to clinical images and the associated contextual patient record. Its technology has provens the commercial and regulatory viability of imaging Real World Data, an emerging market, and provides regulatory-grade, image-centric iRWDTM. Geographically, it operates in Americas, Europe and Middle East, and Asia Pacific. It derives maximum revenue from Europe and Middle East.